We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Morphometric, Clinical and Histological Study on One Stage Bone Augmentation Using BoneCeramic (BCP) and Collagen Membranes (BCP+Collagen)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00835432
Recruitment Status : Completed
First Posted : February 3, 2009
Last Update Posted : February 3, 2009
Information provided by:

Study Description
Brief Summary:

Prospective randomized assessment of alveolar ridge alterations after augmenting dehisced areas by applying principles of guided bone regeneration (GBR) subsequently to implant installation.

Ossix as cross-linked and BioGide as non cross-linked degradable collagen membranes, both used in combination with biphasic Calcium-Phosphate (BoneCeramic) as bone substitute. Clinical measurements and impressions from the sites of interest are to be taken at the stage of augmentation and 6 months after. At six months re-entry non-standardized biopsies from augmented sites will be taken to determine newly grown tissue in quality and quantity.

Due to different degradation characteristics of the two collagen membranes used as barrier, amount of newly formed mineralized tissue is suspected to vary in tests and controls, respectively.

Condition or disease Intervention/treatment Phase
Dehiscent Type of Alveolar Bone Defect One Stage Bone Augmentation Device: Ossix Device: Biogide Phase 4

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Prospective Clinical, Morphometric and Histological Study on Augmentation Using BoneCeramic as Bone Substitute in Combination With Either Cross-Linked or Non Cross-Linked Collagen Membrane in Dehiscent Type of Defects .
Study Start Date : October 2005
Primary Completion Date : January 2007
Study Completion Date : January 2007
Arms and Interventions

Intervention Details:
    Device: Ossix
    Test group
    Other Name: cross-linked collagen membrane barrier
    Device: Biogide
    Other Name: non cross-linked collagen membrane barrier

Outcome Measures

Primary Outcome Measures :
  1. Alteration in width of alveolar bone at implant location after augmentation in mm [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. Histomorphometry in regard to areas occupied by bone to soft tissue to grafting material [ Time Frame: 6 months ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   22 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • alveolar ridge deficiences after tooth loss

Exclusion Criteria:

  • systemic disorders (diabetes mellitus, morbus crown, etc.)
  • pregnancy or lactating period
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00835432

Sponsors and Collaborators
Charite University, Berlin, Germany
Principal Investigator: Anton Friedmann, Dr., PhD Department of Periodontology Charité Center3 CBF, Assmannshauser Str. 4-6, 14197 Berlin, Germany
More Information

Responsible Party: Dr. Anton Friedmann, Department of Periodontology, Charité Center 3, Berlin, Germany
ClinicalTrials.gov Identifier: NCT00835432     History of Changes
Other Study ID Numbers: EA/2/054
First Posted: February 3, 2009    Key Record Dates
Last Update Posted: February 3, 2009
Last Verified: February 2009

Keywords provided by Charite University, Berlin, Germany:
Lateral augmentation
collagen membrane